<DOC>
	<DOCNO>NCT01568112</DOCNO>
	<brief_summary>The primary objective study evaluate whether premedication 325 mg microcoated aspirin ( ASA ) tablet slow-titration dosing schedule BG00012 reduce incidence severity flush GI event follow oral administration BG00012 dose 240 mg twice day ( BID ) healthy volunteer . The secondary objective study evaluate safety tolerability BG00012 administer orally 240 mg BID dose regimen without 325 mg ASA premedication follow slow-titration dose schedule healthy volunteer .</brief_summary>
	<brief_title>Effect Aspirin Pretreatment Slow Dose Titration Flushing Gastrointestinal Events Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate</brief_title>
	<detailed_description />
	<mesh_term>Flushing</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Dimethyl Fumarate</mesh_term>
	<criteria>Key Must give write informed consent authorization require local law Must body mass index ( BMI ) 18.0 34.0 kg/m^2 , inclusive . Ability complete tolerability scale accurately use handheld subject reporting device Subjects childbearing potential must willing practice effective contraception Key History clinically significant disease History severe allergic anaphylactic reaction Intolerance aspirin nonsteroidal antiinflammatory drug ( NSAIDs ) Diarrhea , constipation , abdominal pain , flush nausea within 28 day prior Day 1 NOTE : Other protocol define Inclusion/Exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>BG00012</keyword>
	<keyword>gastrointestinal event</keyword>
	<keyword>flush event</keyword>
	<keyword>dose titration</keyword>
	<keyword>pre-medication</keyword>
	<keyword>aspirin</keyword>
</DOC>